| scholarly article | Q13442814 |
| P50 | author | Michael Givskov | Q30329016 |
| Gerald Pier | Q38326393 | ||
| Massimo Conese | Q40235787 | ||
| Jens Bo Andersen | Q40705929 | ||
| Alessandra Bragonzi | Q43269735 | ||
| P2093 | author name string | Morten Hentzer | |
| Martina Ulrich | |||
| Dieter Worlitzsch | |||
| Gerd Doring | |||
| Petra Timpert | |||
| P2860 | cites work | Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 |
| Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients | Q24551181 | ||
| Cystic fibrosis | Q28212180 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy | Q48106984 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Bacterial transcription factors involved in global regulation | Q56902186 | ||
| Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases | Q67515117 | ||
| A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia | Q68544977 | ||
| Pseudomonas aeruginosa in cystic fibrosis: role of mucC in the regulation of alginate production and stress sensitivity | Q73917235 | ||
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA | Q28492750 | ||
| Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis | Q28493131 | ||
| Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis | Q33903005 | ||
| Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients | Q33963695 | ||
| Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection | Q34058988 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection | Q34531184 | ||
| Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. | Q35106317 | ||
| Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice | Q35408151 | ||
| Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection | Q35555504 | ||
| Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients | Q36528781 | ||
| Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients | Q37208228 | ||
| A rat model of chronic respiratory infection with Pseudomonas aeruginosa | Q39663990 | ||
| Alginate production by clinical nonmucoid Pseudomonas aeruginosa strains. | Q40190281 | ||
| Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis | Q40200920 | ||
| Relevance of animal models for chronic bacterial airway infections in humans | Q40537117 | ||
| Isolation and assay of Pseudomonas aeruginosa alginate | Q40687452 | ||
| Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis | Q41144869 | ||
| Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. | Q45115153 | ||
| Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice | Q45252511 | ||
| Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. | Q47855663 | ||
| Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. | Q47946251 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| cystic fibrosis | Q178194 | ||
| patient | Q181600 | ||
| P304 | page(s) | 410-419 | |
| P577 | publication date | 2005-06-24 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model | |
| P478 | volume | 192 |
| Q40470197 | A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection. |
| Q35446017 | Affecting Pseudomonas aeruginosa phenotypic plasticity by quorum sensing dysregulation hampers pathogenicity in murine chronic lung infection |
| Q36968815 | Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. |
| Q64077063 | Anaerobiosis influences virulence properties of Pseudomonas aeruginosa cystic fibrosis isolates and the interaction with Staphylococcus aureus |
| Q34180324 | BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs |
| Q44861090 | Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa |
| Q39958926 | Burkholderia cenocepacia strains isolated from cystic fibrosis patients are apparently more invasive and more virulent than rhizosphere strains |
| Q28492934 | Cell wall-inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: Roles of sigma (AlgT) and the AlgW and Prc proteases |
| Q33756667 | Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions. |
| Q35880930 | Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection. |
| Q37721418 | Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa |
| Q36556391 | Cystic fibrosis mouse models |
| Q34256578 | Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts |
| Q42043676 | Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia. |
| Q33705998 | Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients |
| Q42406600 | Distribution, organization, and ecology of bacteria in chronic wounds |
| Q36051231 | Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia. |
| Q47135274 | Environmental Burkholderia cenocepacia Strain Enhances Fitness by Serial Passages during Long-Term Chronic Airways Infection in Mice |
| Q39450212 | Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. |
| Q30414550 | Genes required for and effects of alginate overproduction induced by growth of Pseudomonas aeruginosa on Pseudomonas isolation agar supplemented with ammonium metavanadate |
| Q38178755 | Genetics and regulation of bacterial alginate production |
| Q30441313 | Genome-scale metabolic network analysis of the opportunistic pathogen Pseudomonas aeruginosa PAO1 |
| Q41763271 | Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q42260006 | Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins |
| Q36313798 | In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients |
| Q43112697 | In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection |
| Q41808232 | Insights into the assembly of the alginate biosynthesis machinery in Pseudomonas aeruginosa. |
| Q38614351 | Lentiviral vectors and cystic fibrosis gene therapy |
| Q42221270 | Long term chronic Pseudomonas aeruginosa airway infection in mice |
| Q24678466 | Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum |
| Q30394473 | Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response |
| Q33393593 | MucR, a novel membrane-associated regulator of alginate biosynthesis in Pseudomonas aeruginosa |
| Q30995330 | NMR and MALDI-TOF MS based characterization of exopolysaccharides in anaerobic microbial aggregates from full-scale reactors |
| Q57036685 | Nitrosative stress inhibits production of the virulence factor alginate in mucoidPseudomonas aeruginosa |
| Q37413900 | Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis |
| Q64935177 | Outer-membrane protein LptD (PA0595) plays a role in the regulation of alginate synthesis in Pseudomonas aeruginosa. |
| Q37714870 | Oxygen limitation within a bacterial aggregate |
| Q40130929 | Oxygen-dependent regulation of c-di-GMP synthesis by SadC controls alginate production in Pseudomonas aeruginosa. |
| Q33815381 | Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection |
| Q38234646 | Progress towards next-generation therapeutics for cystic fibrosis |
| Q41909195 | Prophylactic and therapeutic efficacy of a fully human immunoglobulin G1 monoclonal antibody to Pseudomonas aeruginosa alginate in murine keratitis infection |
| Q27694585 | Proteolytic regulation of alginate overproduction in Pseudomonas aeruginosa. |
| Q29346816 | Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner |
| Q30252902 | Pseudomonas aeruginosa Alginate Overproduction Promotes Coexistence with Staphylococcus aureus in a Model of Cystic Fibrosis Respiratory Infection |
| Q38273318 | Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. |
| Q41758615 | Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs |
| Q33287382 | Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling |
| Q35808927 | Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa |
| Q36147683 | Regulation of bacterial virulence gene expression by cell envelope stress responses |
| Q64258896 | Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of |
| Q40245763 | Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. |
| Q33749315 | Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy |
| Q92967250 | Selection and validation of reference genes for gene expression studies in Pseudomonas brassicacearum GS20 using real-time quantitative reverse transcription PCR |
| Q59133957 | Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis |
| Q39281402 | Surfactant protein A blocks recognition of Pseudomonas aeruginosa by CKAP4/P63 on airway epithelial cells. |
| Q35689470 | Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants |
| Q34596119 | Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model |
| Q47662409 | Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection. |
| Q28492791 | The Pseudomonas aeruginosa sensor kinase KinB negatively controls alginate production through AlgW-dependent MucA proteolysis |
| Q40287211 | The Pseudomonas aeruginosa two-component regulator AlgR directly activates rsmA expression in a phosphorylation independent manner |
| Q35732371 | The capability of Pseudomonas aeruginosa to recruit zinc under conditions of limited metal availability is affected by inactivation of the ZnuABC transporter |
| Q38349818 | The expanding roles of c-di-GMP in the biosynthesis of exopolysaccharides and secondary metabolites. |
| Q39426830 | The role of bacterial biofilms in chronic infections |
| Q36290528 | Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge |
| Q38522938 | Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections. |
| Q28266964 | Vaccines and immunotherapy against Pseudomonas aeruginosa |
| Q26852817 | Vaccines for Pseudomonas aeruginosa: a long and winding road |
| Q30426237 | Vanadate and triclosan synergistically induce alginate production by Pseudomonas aeruginosa strain PAO1. |
| Q39798133 | Which bacterial biofilm exopolysaccharide is preferred, Psl or alginate? |
Search more.